Despite having the power to set the list price for their medications, pharmaceutical companies are driven by profit and ...

Asthma sufferers in the UAE who rely on Ventolin to relieve symptoms are struggling to refill their medication, with many ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family.

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Discover 7 surprising ways asthma develops in adulthood – from workplace exposures to hormonal shifts. Frequently begins ...

A pair of Wisconsin legislators have introduced a bill to combat what they call “predatory practices” from pharmacy benefit ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...